Argentine President Alberto Fernandez received the first dose of the Russian Sputnik V vaccine in ArgentinaBUENOS AIRES, 29 Jan. Argentine President Alberto Fernandez called the lack of approval of the Russian Sputnik V vaccine by a number of European countries and the World Health Organization (WHO) a mistake. that it is dictated by geopolitical considerations, because we have a body for the control and approval of medicines and vaccines, which is one of the most qualified in the world … I know that our body is very demanding, and it approved it (the vaccine — ed.), so I have no explanation why it takes so long in Europe,» the president said in an interview with RT.The heads of the Ministry of Health of Russia and Argentina discussed the effectiveness of Sputnik V. He also added that he had spoken to European leaders and WHO Director General Tedros Adhanom Ghebreyesus about the effectiveness of the Russian vaccine. Earlier, a representative of the presidential administration of Argentina told RIA Novosti that Fernandez expected to meet with Russian President Vladimir Putin 3 February. Since March 4, 2021, «Sputnik V» has been undergoing a gradual examination procedure at the European Medicines Agency, which approves drugs for centralized use in the European Union. «Sputnik V» has been approved in 71 countries with a total population of 4 billion people, which is more than 50% the population of the earth. In terms of the number of government regulator approvals received, Sputnik V ranks second in the world. The effectiveness of the vaccine was 97.6% based on an analysis of data from 3.8 million vaccinated Russians, which is higher than the data published earlier by the medical journal The Lancet (91.6%), reported by the Russian Direct Investment Fund (RDIF) and Gamaleya Research Center. Data on the use of Sputnik V during vaccination of the population in a number of countries (Argentina, San Marino, Serbia, Hungary, Bahrain, Mexico, the United Arab Emirates and others) demonstrate that Sputnik V is one of the safest and most effective vaccines against coronavirus , RDIF reported.
